Amarantus Subsidiary Elto Pharma Receives Notice of Allowance for European Patent Application Covering Method of Treating Cognitive Impairment Associated with Alzheimer’s Disease and Parkinson’s disea
The original release is unavailable here.
The original release is unavailable here.